|Desc||CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A|
[PMID 21061336] p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck
[PMID 20453839] Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.
[PMID 20919861] Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence.
[PMID 21381012] p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
[PMID 24104554] Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy
[PMID 23218882] Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.
[PMID 26575185] Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA
[PMID 27279837] Analysis of possible genetic risk factors contributing to development of childhood acute lymphoblastic leukaemia in the Latvian population.
[PMID 28768142] Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
[PMID 31028217] Impact of MDM2, TP53 and P14ARF Polymorphisms on Endometrial Cancer Risk and Onset.